Evidence map›Paper›PMID 28744216›Full record

ArticleFrontiers in pharmacology2017

Nuclear Magnetic Resonance-Based Metabolomics Approach to Evaluate the Prevention Effect of

Ming-Hui Li, Hong-Zhi Du, Gui-Ju Kong, Li-Bao Liu, Xin-Xin Li, Sen-Sen Lin, Ai-Qun Jia, Sheng-Tao Yuan, Li Sun, Jun-Song Wang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Hepatoprotective effects ofPharmaceutical biology · 2020
    Article
  5. Neuroprotective effects ofFood science & nutrition · 2020
    Article
  6. Article
  7. Article
  8. OncoTargets and therapy · 2019
    Article
  9. Frontiers in pharmacology · 2019
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Ming-Hui LiCenter for Molecular Metabolism, Nanjing University of Science and TechnologyNanjing, China.
Hong-Zhi DuJiangsu Key Laboratory of Drug Screening and Jiangsu Center for Pharmacodynamics Research and Evaluation, China Pharmaceutical UniversityNanjing, China.
Gui-Ju KongJiangsu Key Laboratory of Drug Screening and Jiangsu Center for Pharmacodynamics Research and Evaluation, China Pharmaceutical UniversityNanjing, China.
Li-Bao LiuDepartment of Cardiothoracic Surgery, The Third Affiliated Hospital, Sun Yat-Sen UniversityGuangzhou, China.
Xin-Xin LiTasly Research Institute, Tianjin Tasly Holding Group Co. Ltd.Tianjin, China.
Sen-Sen LinJiangsu Key Laboratory of Drug Screening and Jiangsu Center for Pharmacodynamics Research and Evaluation, China Pharmaceutical UniversityNanjing, China.
Ai-Qun JiaSchool of Environmental and Biological Engineering, Nanjing University of Science and TechnologyNanjing, China.
Sheng-Tao YuanJiangsu Key Laboratory of Drug Screening and Jiangsu Center for Pharmacodynamics Research and Evaluation, China Pharmaceutical UniversityNanjing, China.
Li SunJiangsu Key Laboratory of Drug Screening and Jiangsu Center for Pharmacodynamics Research and Evaluation, China Pharmaceutical UniversityNanjing, China.
Jun-Song WangCenter for Molecular Metabolism, Nanjing University of Science and TechnologyNanjing, China.
China Pharmaceutical University · CNNanjing University of Science and Technology · CNTasly Holding Group (China) · CNThird Affiliated Hospital of Sun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer (CRC) is one of the most common malignant tumors worldwide, occurring in the colon or rectum portion of large intestine. With marked antioxidant, anti-inflammation and anti-tumor activities,

Indexed as

AOM/DSSCamellia nitidissima Chicolorectal carcinogenesiscorrelation network analysismetabolomicsOPLS-DA

Identifiers

PMID28744216
PMCPMC5504182
OpenAlexW2735516883

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.